Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intermediate mutation frequencies favor evolution of multidrug resistance in Escherichia coli.

Literature DB >> 15965238

Intermediate mutation frequencies favor evolution of multidrug resistance in Escherichia coli.

Erick Denamur¹, Olivier Tenaillon, Catherine Deschamps, David Skurnik, Esthel Ronco, Jean Louis Gaillard, Bertrand Picard, Catherine Branger, Ivan Matic.

Abstract

In studying the interplay between mutation frequencies and antibiotic resistance among Escherichia coli natural isolates, we observed that modest modifications of mutation frequency may significantly influence the evolution of antibiotic resistance. The strains having intermediate mutation frequencies have significantly more antibiotic resistances than strains having low and high mutation frequencies.

Entities: Species

Mesh：

Substances：
Anti-Bacterial Agents

Year: 2005 PMID： 15965238 PMCID： PMC1456789 DOI： 10.1534/genetics.105.045526

Source DB: PubMed Journal: Genetics ISSN： 0016-6731 Impact factor: 4.562

22 in total

1. Costs and benefits of high mutation rates: adaptive evolution of bacteria in the mouse gut.

Authors: A Giraud; I Matic; O Tenaillon; A Clara; M Radman; M Fons; F Taddei
Journal: Science Date: 2001-03-30 Impact factor: 47.728

2. The population genetics of ecological specialization in evolving Escherichia coli populations.

Authors: V S Cooper; R E Lenski
Journal: Nature Date: 2000-10-12 Impact factor: 49.962

3. Mutators, population size, adaptive landscape and the adaptation of asexual populations of bacteria.

Authors: O Tenaillon; B Toupance; H Le Nagard; F Taddei; B Godelle
Journal: Genetics Date: 1999-06 Impact factor: 4.562

4. High frequency of mutator strains among human uropathogenic Escherichia coli isolates.

Authors: Erick Denamur; Stéphane Bonacorsi; Antoine Giraud; Patrick Duriez; Farida Hilali; Christine Amorin; Edouard Bingen; Antoine Andremont; Bertrand Picard; François Taddei; Ivan Matic
Journal: J Bacteriol Date: 2002-01 Impact factor: 3.490

5. Role of mutator alleles in adaptive evolution.

Authors: F Taddei; M Radman; J Maynard-Smith; B Toupance; P H Gouyon; B Godelle
Journal: Nature Date: 1997-06-12 Impact factor: 49.962

6. Proliferation of mutators in A cell population.

Authors: E F Mao; L Lane; J Lee; J H Miller
Journal: J Bacteriol Date: 1997-01 Impact factor: 3.490

7. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.

Authors: A Oliver; R Cantón; P Campo; F Baquero; J Blázquez
Journal: Science Date: 2000-05-19 Impact factor: 47.728

8. The consequences of growth of a mutator strain of Escherichia coli as measured by loss of function among multiple gene targets and loss of fitness.

Authors: P Funchain; A Yeung; J L Stewart; R Lin; M M Slupska; J H Miller
Journal: Genetics Date: 2000-03 Impact factor: 4.562

Review 9. Lethal mutagenesis of HIV.

Authors: Robert A Smith; Lawrence A Loeb; Bradley D Preston
Journal: Virus Res Date: 2005-02 Impact factor: 3.303

10. Genetic background of Escherichia coli and extended-spectrum beta-lactamase type.

Authors: Catherine Branger; Oana Zamfir; Sabine Geoffroy; Geneviève Laurans; Guillaume Arlet; Hoang Vu Thien; Stéphanie Gouriou; Bertrand Picard; Erick Denamur
Journal: Emerg Infect Dis Date: 2005-01 Impact factor: 6.883

22 in total

1. Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections.

Authors: Ashley E Warren; Carla M Boulianne-Larsen; Christine B Chandler; Kami Chiotti; Evgueny Kroll; Scott R Miller; Francois Taddei; Isabelle Sermet-Gaudelus; Agnes Ferroni; Kathleen McInnerney; Michael J Franklin; Frank Rosenzweig
Journal: Infect Immun Date: 2011-09-19 Impact factor: 3.441

Intermediate mutation frequencies favor evolution of multidrug resistance in Escherichia coli.

1. Costs and benefits of high mutation rates: adaptive evolution of bacteria in the mouse gut.

2. The population genetics of ecological specialization in evolving Escherichia coli populations.

3. Mutators, population size, adaptive landscape and the adaptation of asexual populations of bacteria.

4. High frequency of mutator strains among human uropathogenic Escherichia coli isolates.

5. Role of mutator alleles in adaptive evolution.

6. Proliferation of mutators in A cell population.

7. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.

8. The consequences of growth of a mutator strain of Escherichia coli as measured by loss of function among multiple gene targets and loss of fitness.

Review 9. Lethal mutagenesis of HIV.

10. Genetic background of Escherichia coli and extended-spectrum beta-lactamase type.

1. Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections.

Review 2. Noise-driven heterogeneity in the rate of genetic-variant generation as a basis for evolvability.

3. Weak mutators can drive the evolution of fluoroquinolone resistance in Escherichia coli.

4. The balance between mutators and nonmutators in asexual populations.

5. Competition between transposable elements and mutator genes in bacteria.

6. Antibiotic-resistant soil bacteria in transgenic plant fields.

7. Phages limit the evolution of bacterial antibiotic resistance in experimental microcosms.

8. Evolutionary origins of invasive populations.

9. Parasitic plants have increased rates of molecular evolution across all three genomes.

10. β-Lactam antibiotics promote bacterial mutagenesis via an RpoS-mediated reduction in replication fidelity.